Open AccessIloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second‐generation antipsychotic
Author(s) -
Citrome L.
Publication year - 2009
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/j.1742-1241.2009.02142.x
Subject(s) - medicine , tolerability , positive and negative syndrome scale , antipsychotic , placebo , atypical antipsychotic , number needed to treat , schizophrenia (object oriented programming) , clinical trial , pharmacology , psychiatry , psychosis , adverse effect , pathology , alternative medicine
The aim of the study was to describe the efficacy and safety of iloperidone for the treatment of schizophrenia.